Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novonix (NVX) Liabilities and Shareholders Equity (2020 - 2025)

Novonix (NVX) has 6 years of Liabilities and Shareholders Equity data on record, last reported at $282.9 million in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 25.13% year-over-year to $282.9 million; the TTM value through Dec 2025 reached $1.0 billion, down 2.95%, while the annual FY2025 figure was $282.9 million, 25.13% up from the prior year.
  • Liabilities and Shareholders Equity reached $282.9 million in Q4 2025 per NVX's latest filing, up from $226.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $314.8 million in Q2 2022 and bottomed at $156.2 million in Q2 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $253.5 million, with a median of $270.4 million recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 201.81% in 2021, then decreased 14.14% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $156.2 million in 2021, then surged by 77.6% to $277.4 million in 2022, then decreased by 5.08% to $263.3 million in 2023, then fell by 14.14% to $226.1 million in 2024, then rose by 25.13% to $282.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $282.9 million in Q4 2025, $226.1 million in Q4 2024, and $263.3 million in Q4 2023.